We are international
Donate
• about myeloma TEXT SIZE   
get the correct diagnosis

STEP 2 - REFERENCES
08.18.11

STEP 2- REFERENCES

  1. Prognostic Factors and Staging in Multiple Myeloma: A Reappraisal. Bataille Journal of Clinical Oncology. 1986 4:80-87. Vol. 4 no. 1

  2. Whole Body 18 F-FDG PET Identifies High-Risk Myeloma. Durie. Journal of Nuclear Medicine 2002; 43: 1457-1463

  3. International Staging System for Multiple Myeloma. Greipp Journal of Clinical Oncology. 2005 Journal of Clinical Oncology Vol. 23 Number 15

  4. The Role of Anatomic and Functional Staging in Myeloma: Description of Durie/Salmon plus staging system Durie European Journal of Cancer 42 (2006) 1539-1543

  5. Magnetic Resonance Imaging in Multiple Myeloma: Diagnostic & Clinical Implications: Walker, Journal of Clinical Oncology. 2007 Volume 25 No. 9.1

  6. Myeloma in Patients Younger than 50 years presents with more favorable features & shows better survival. An analysis of 10,549 patients from the IMWG. Ludwig 2008 BLOOD 111:4039-4047

  7. Suppression of abnormal karyotype predicts superior survival in multiple myeloma. Arzoumanian. Leukemia 2008. 22 850-855

  8. IMWG Guidelines for serum-free light chain analysis in multiple myeloma and related disorders Dispenzieri 2009 Leukemia 23 215-224

  9. The molecular characteristics and clinical management of multiple myeloma in the post-genomic era. Zhou. Leukemia 2009, 23, 1941-1956

  10. Consensus recommendations for standard investigative work-up: report of the IMWG. Dimopoulos 2011. 117-4701-4705

  11. Advances in Imaging & the management of myeloma bone disease. Terpos Journal of Clinical Oncology. Vol. 29 No. 14

  12. Clinical & Biological Features of t(4:14)multiple myeloma: a prospective study. Karlin Leukemia & Lymphoma: 2011: 52(2):238-246

  13. Initial Genome Sequencing and Analysis of multiple myeloma. Chapman NATURE 2011 Vol. 471 doi: 10.1038/nature09837

  14. Multiple Myeloma: 2011 Update on diagnosis, risk stratification and management. Rajkumar 2010: AJH Educational Material

  15. 18-F-flouro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: A Systemic Review. Lammeren-Venema 2012 Cancer Vol. 118. Issue 8. 1971-1981

  16. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells. Schmidt-Hieber et al.  Haematologica 2012; 98(2): 279-287

  17. Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders. Fiona et al. Haematologica  2012; 97(8): 1272-1280.

 related articles